Seer (SEER) Amortizatization of Intangibles (2020 - 2026)
Seer (SEER) posted quarterly Amortizatization of Intangibles of $767000.0 for Q1 2026, down 30.53% year-over-year from $1.1 million in Q1 2025, and up 336.0% quarter-over-quarter from -$325000.0 in Q4 2025.
Powered by 
Analysis
Seer (SEER) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Seer's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $767000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 30.53% year-over-year to $767000.0; the TTM figure through Mar 2026 stood at $804000.0 (down 55.48% YoY), while the FY2025 annual figure was $1.1 million, down 62.63% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $767000.0, up from -$325000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.4 million in Q1 2024, with the low at -$3.2 million in Q3 2023.
- The 5-year median for Amortizatization of Intangibles is -$132000.0 (2022), against an average of -$436470.6.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles plunged 2510.4% in 2023, then jumped 198.86% in 2024.
- Seer's Amortizatization of Intangibles stood at -$1.1 million in 2022, then tumbled by 163.42% to -$3.0 million in 2023, then soared by 116.45% to $494000.0 in 2024, then plunged by 165.79% to -$325000.0 in 2025, then soared by 336.0% to $767000.0 in 2026.
- Business Quant data shows SEER's Amortizatization of Intangibles at $767000.0 in Q1 2026, -$325000.0 in Q4 2025, and $645000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 678,000.00 |
| 10 | Seer | 107.29 Mn | 107.29 Mn | 1.51 Mn | -276,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -276,000.00 |
| Mar 31, 2026 | 767,000.00 |
| Dec 31, 2025 | -325,000.00 |
| Sep 30, 2025 | 645,000.00 |
| Jun 30, 2025 | -283,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 494,000.00 |
| Sep 30, 2024 | 605,000.00 |
| Jun 30, 2024 | -397,000.00 |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Sep 30, 2023 | -3.15 Mn |
| Jun 30, 2023 | -3.01 Mn |
| Mar 31, 2023 | -2.38 Mn |
| Dec 31, 2022 | -1.14 Mn |
| Sep 30, 2022 | -132,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Mar 31, 2022 | 314,000.00 |
| Dec 31, 2021 | 378,000.00 |
| Sep 30, 2021 | 407,000.00 |